{"id":20874,"date":"2026-10-28T16:00:05","date_gmt":"2026-10-28T16:00:05","guid":{"rendered":"https:\/\/www.lymphoma.ca\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\/"},"modified":"2026-10-28T16:00:11","modified_gmt":"2026-10-28T16:00:11","slug":"le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur","status":"publish","type":"post","link":"https:\/\/www.lymphoma.ca\/fr\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\/","title":{"rendered":"Le retour au travail apr\u00e8s un cancer h\u00e9matologique et les traitements de type allogreffe (provenant d\u2019un donneur)"},"content":{"rendered":"[vc_row type=\u00a0\u00bbin_container\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb text_color=\u00a0\u00bbdark\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bbnone\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb overflow=\u00a0\u00bbvisible\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_direction_desktop=\u00a0\u00bbdefault\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb desktop_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_backdrop_filter=\u00a0\u00bbnone\u00a0\u00bb column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb column_position=\u00a0\u00bbdefault\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/1&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb animation_type=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][vc_column_text css=\u00a0\u00bb\u00a0\u00bb text_direction=\u00a0\u00bbdefault\u00a0\u00bb]\n<h2>Le retour au travail apr\u00e8s un cancer h\u00e9matologique et les traitements de type allogreffe (provenant d\u2019un donneur)<\/h2>\n<h3><strong>Date et Heure :<\/strong> Lundi 16 novembre 2026 de 16h00 \u00e0 17h00<\/h3>\n<h3><strong><\/strong>Avec Dre Karine Bilodeau<\/h3>\n<h3><strong>Lieu:<\/strong><\/h3>\n<p>En ligne<\/p>\n<h3><strong>Description<\/strong><\/h3>\n<p class=\"x_MsoNormal\" data-olk-copy-source=\"MessageBody\">Les patients atteints d\u2019un cancer h\u00e9matologique \u00e9prouvent de nombreux d\u00e9fis lorsqu\u2019ils retournent au travail apr\u00e8s leur traitement, notamment \u00e0 la suite d\u2019une allogreffe. Ce webinaire portera principalement sur l\u2019exp\u00e9rience des patients qui retournent au travail \u00e0 la suite de leur traitement, soulignant les d\u00e9fis et les barri\u00e8res, et fournira des recommandations et des ressources pour faciliter cette transition. Ce webinaire est pertinent pour les patients atteints de lymphome et leurs proches aidants qui cherchent \u00e0 les soutenir.<\/p>\n<h3><strong>Biographie de la conf\u00e9renci\u00e8re :<\/strong><\/h3>\n<p><span style=\"color: #800080;\"><strong>Dr. Karine Bilodeau<\/strong><\/span> est professeure agr\u00e9g\u00e9e \u00e0 la Facult\u00e9 des sciences infirmi\u00e8res de l\u2019Universit\u00e9 de Montr\u00e9al et chercheuse r\u00e9guli\u00e8re au Centre de recherche de l&rsquo;H\u00f4pital Maisonneuve-Rosemont (CRHMR). Elle est titulaire de la Chaire en recherche \u00e9valuative et en exp\u00e9rience patient en oncologie. Docteure en sciences infirmi\u00e8res, elle se sp\u00e9cialise dans les soins et les services en oncologie, particuli\u00e8rement dans les transitions v\u00e9cues par les personnes atteintes d\u2019un cancer. Ses travaux portent notamment sur le retour au travail apr\u00e8s un cancer, l&rsquo;am\u00e9lioration des services pour les jeunes adultes touch\u00e9s par le cancer (18-39 ans) ainsi que sur les trajectoires de soutien.<br \/>[\/vc_column_text][\/vc_column][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_direction_desktop=\u00a0\u00bbdefault\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb desktop_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_backdrop_filter=\u00a0\u00bbnone\u00a0\u00bb column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb column_position=\u00a0\u00bbdefault\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/1&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb animation_type=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][divider line_type=\u00a0\u00bbNo Line\u00a0\u00bb][nectar_btn size=\u00a0\u00bblarge\u00a0\u00bb open_new_tab=\u00a0\u00bbtrue\u00a0\u00bb button_style=\u00a0\u00bbregular\u00a0\u00bb button_color_2=\u00a0\u00bbAccent-Color\u00a0\u00bb icon_family=\u00a0\u00bbnone\u00a0\u00bb text=\u00a0\u00bbS&#039;inscrire maintenant\u00a0\u00bb url=\u00a0\u00bbhttps:\/\/register.gotowebinar.com\/register\/4715677186843858775&Prime;][\/vc_column][\/vc_row]\n","protected":false},"excerpt":{"rendered":"<p>[vc_row type=\u00a0\u00bbin_container\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb text_color=\u00a0\u00bbdark\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bbnone\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb overflow=\u00a0\u00bbvisible\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_direction_desktop=\u00a0\u00bbdefault\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb desktop_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_backdrop_filter=\u00a0\u00bbnone\u00a0\u00bb column_shadow=\u00a0\u00bbnone\u00a0\u00bb&#8230;<\/p>\n","protected":false},"author":6,"featured_media":20870,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"categories":[72],"tags":[],"class_list":["post-20874","post","type-post","status-publish","format-standard","has-post-thumbnail","category-other-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Le retour au travail apr\u00e8s un cancer h\u00e9matologique et les traitements de type allogreffe (provenant d\u2019un donneur) - Lymphoma Canada<\/title>\n<meta name=\"description\" content=\"Les patients atteints d\u2019un cancer h\u00e9matologique \u00e9prouvent de nombreux d\u00e9fis lorsqu\u2019ils retournent au travail apr\u00e8s leur traitement, notamment \u00e0 la suite d\u2019une allogreffe.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.lymphoma.ca\/fr\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Le retour au travail apr\u00e8s un cancer h\u00e9matologique et les traitements de type allogreffe (provenant d\u2019un donneur) - Lymphoma Canada\" \/>\n<meta property=\"og:description\" content=\"Les patients atteints d\u2019un cancer h\u00e9matologique \u00e9prouvent de nombreux d\u00e9fis lorsqu\u2019ils retournent au travail apr\u00e8s leur traitement, notamment \u00e0 la suite d\u2019une allogreffe.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.lymphoma.ca\/fr\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\/\" \/>\n<meta property=\"og:site_name\" content=\"Lymphoma Canada\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/LymphomaCanada\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-28T16:00:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-28T16:00:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2026\/10\/Featured-image-website-Final-12.png\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"laurad\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@lymphomacanada\" \/>\n<meta name=\"twitter:site\" content=\"@lymphomacanada\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"laurad\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.lymphoma.ca\\\/fr\\\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.lymphoma.ca\\\/fr\\\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\\\/\"},\"author\":{\"name\":\"laurad\",\"@id\":\"https:\\\/\\\/www.lymphoma.ca\\\/fr\\\/#\\\/schema\\\/person\\\/a140ae13bdc702e5a6defcdf6513458c\"},\"headline\":\"Le retour au travail apr\u00e8s un cancer h\u00e9matologique et les traitements de type allogreffe (provenant d\u2019un donneur)\",\"datePublished\":\"2026-10-28T16:00:05+00:00\",\"dateModified\":\"2026-10-28T16:00:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.lymphoma.ca\\\/fr\\\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\\\/\"},\"wordCount\":557,\"publisher\":{\"@id\":\"https:\\\/\\\/www.lymphoma.ca\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.lymphoma.ca\\\/fr\\\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.lymphoma.ca\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Featured-image-website-Final-12.png\",\"articleSection\":[\"other-fr\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.lymphoma.ca\\\/fr\\\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\\\/\",\"url\":\"https:\\\/\\\/www.lymphoma.ca\\\/fr\\\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\\\/\",\"name\":\"Le retour au travail apr\u00e8s un cancer h\u00e9matologique et les traitements de type allogreffe (provenant d\u2019un donneur) - Lymphoma Canada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.lymphoma.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.lymphoma.ca\\\/fr\\\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.lymphoma.ca\\\/fr\\\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.lymphoma.ca\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Featured-image-website-Final-12.png\",\"datePublished\":\"2026-10-28T16:00:05+00:00\",\"dateModified\":\"2026-10-28T16:00:11+00:00\",\"description\":\"Les patients atteints d\u2019un cancer h\u00e9matologique \u00e9prouvent de nombreux d\u00e9fis lorsqu\u2019ils retournent au travail apr\u00e8s leur traitement, notamment \u00e0 la suite d\u2019une allogreffe.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.lymphoma.ca\\\/fr\\\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.lymphoma.ca\\\/fr\\\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.lymphoma.ca\\\/fr\\\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.lymphoma.ca\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Featured-image-website-Final-12.png\",\"contentUrl\":\"https:\\\/\\\/www.lymphoma.ca\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Featured-image-website-Final-12.png\",\"width\":600,\"height\":400,\"caption\":\"Returning to Work After Hematological Cancer\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.lymphoma.ca\\\/fr\\\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.lymphoma.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Le retour au travail apr\u00e8s un cancer h\u00e9matologique et les traitements de type allogreffe (provenant d\u2019un donneur)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.lymphoma.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.lymphoma.ca\\\/fr\\\/\",\"name\":\"Lymphoma Canada\",\"description\":\"Information. Help. Hope.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.lymphoma.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.lymphoma.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.lymphoma.ca\\\/fr\\\/#organization\",\"name\":\"Lymphoma Canada\",\"url\":\"https:\\\/\\\/www.lymphoma.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.lymphoma.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.lymphoma.ca\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/logo-lymphoma.jpg\",\"contentUrl\":\"https:\\\/\\\/www.lymphoma.ca\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/logo-lymphoma.jpg\",\"width\":343,\"height\":343,\"caption\":\"Lymphoma Canada\"},\"image\":{\"@id\":\"https:\\\/\\\/www.lymphoma.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/LymphomaCanada\",\"https:\\\/\\\/x.com\\\/lymphomacanada\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/lymphoma-canada\\\/\",\"http:\\\/\\\/instagram.com\\\/lymphomacanada\",\"http:\\\/\\\/www.youtube.com\\\/user\\\/LymphomaTV\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.lymphoma.ca\\\/fr\\\/#\\\/schema\\\/person\\\/a140ae13bdc702e5a6defcdf6513458c\",\"name\":\"laurad\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a310d914d16438b6f3b5c2cbef3b4cb63a9d9d2f31a73ab227db354519b71d6c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a310d914d16438b6f3b5c2cbef3b4cb63a9d9d2f31a73ab227db354519b71d6c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a310d914d16438b6f3b5c2cbef3b4cb63a9d9d2f31a73ab227db354519b71d6c?s=96&d=mm&r=g\",\"caption\":\"laurad\"},\"url\":\"https:\\\/\\\/www.lymphoma.ca\\\/fr\\\/author\\\/laurad\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Le retour au travail apr\u00e8s un cancer h\u00e9matologique et les traitements de type allogreffe (provenant d\u2019un donneur) - Lymphoma Canada","description":"Les patients atteints d\u2019un cancer h\u00e9matologique \u00e9prouvent de nombreux d\u00e9fis lorsqu\u2019ils retournent au travail apr\u00e8s leur traitement, notamment \u00e0 la suite d\u2019une allogreffe.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.lymphoma.ca\/fr\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\/","og_locale":"fr_FR","og_type":"article","og_title":"Le retour au travail apr\u00e8s un cancer h\u00e9matologique et les traitements de type allogreffe (provenant d\u2019un donneur) - Lymphoma Canada","og_description":"Les patients atteints d\u2019un cancer h\u00e9matologique \u00e9prouvent de nombreux d\u00e9fis lorsqu\u2019ils retournent au travail apr\u00e8s leur traitement, notamment \u00e0 la suite d\u2019une allogreffe.","og_url":"https:\/\/www.lymphoma.ca\/fr\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\/","og_site_name":"Lymphoma Canada","article_publisher":"https:\/\/www.facebook.com\/LymphomaCanada","article_published_time":"2026-10-28T16:00:05+00:00","article_modified_time":"2026-10-28T16:00:11+00:00","og_image":[{"width":600,"height":400,"url":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2026\/10\/Featured-image-website-Final-12.png","type":"image\/png"}],"author":"laurad","twitter_card":"summary_large_image","twitter_creator":"@lymphomacanada","twitter_site":"@lymphomacanada","twitter_misc":{"\u00c9crit par":"laurad","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.lymphoma.ca\/fr\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\/#article","isPartOf":{"@id":"https:\/\/www.lymphoma.ca\/fr\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\/"},"author":{"name":"laurad","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/a140ae13bdc702e5a6defcdf6513458c"},"headline":"Le retour au travail apr\u00e8s un cancer h\u00e9matologique et les traitements de type allogreffe (provenant d\u2019un donneur)","datePublished":"2026-10-28T16:00:05+00:00","dateModified":"2026-10-28T16:00:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.lymphoma.ca\/fr\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\/"},"wordCount":557,"publisher":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#organization"},"image":{"@id":"https:\/\/www.lymphoma.ca\/fr\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\/#primaryimage"},"thumbnailUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2026\/10\/Featured-image-website-Final-12.png","articleSection":["other-fr"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.lymphoma.ca\/fr\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\/","url":"https:\/\/www.lymphoma.ca\/fr\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\/","name":"Le retour au travail apr\u00e8s un cancer h\u00e9matologique et les traitements de type allogreffe (provenant d\u2019un donneur) - Lymphoma Canada","isPartOf":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.lymphoma.ca\/fr\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\/#primaryimage"},"image":{"@id":"https:\/\/www.lymphoma.ca\/fr\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\/#primaryimage"},"thumbnailUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2026\/10\/Featured-image-website-Final-12.png","datePublished":"2026-10-28T16:00:05+00:00","dateModified":"2026-10-28T16:00:11+00:00","description":"Les patients atteints d\u2019un cancer h\u00e9matologique \u00e9prouvent de nombreux d\u00e9fis lorsqu\u2019ils retournent au travail apr\u00e8s leur traitement, notamment \u00e0 la suite d\u2019une allogreffe.","breadcrumb":{"@id":"https:\/\/www.lymphoma.ca\/fr\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.lymphoma.ca\/fr\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.lymphoma.ca\/fr\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\/#primaryimage","url":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2026\/10\/Featured-image-website-Final-12.png","contentUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2026\/10\/Featured-image-website-Final-12.png","width":600,"height":400,"caption":"Returning to Work After Hematological Cancer"},{"@type":"BreadcrumbList","@id":"https:\/\/www.lymphoma.ca\/fr\/le-retour-au-travail-apres-un-cancer-hematologique-et-les-traitements-de-type-allogreffe-provenant-dun-donneur\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.lymphoma.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Le retour au travail apr\u00e8s un cancer h\u00e9matologique et les traitements de type allogreffe (provenant d\u2019un donneur)"}]},{"@type":"WebSite","@id":"https:\/\/www.lymphoma.ca\/fr\/#website","url":"https:\/\/www.lymphoma.ca\/fr\/","name":"Lymphoma Canada","description":"Information. Help. Hope.","publisher":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.lymphoma.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.lymphoma.ca\/fr\/#organization","name":"Lymphoma Canada","url":"https:\/\/www.lymphoma.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg","contentUrl":"https:\/\/www.lymphoma.ca\/wp-content\/uploads\/2023\/05\/logo-lymphoma.jpg","width":343,"height":343,"caption":"Lymphoma Canada"},"image":{"@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/LymphomaCanada","https:\/\/x.com\/lymphomacanada","https:\/\/www.linkedin.com\/company\/lymphoma-canada\/","http:\/\/instagram.com\/lymphomacanada","http:\/\/www.youtube.com\/user\/LymphomaTV"]},{"@type":"Person","@id":"https:\/\/www.lymphoma.ca\/fr\/#\/schema\/person\/a140ae13bdc702e5a6defcdf6513458c","name":"laurad","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/a310d914d16438b6f3b5c2cbef3b4cb63a9d9d2f31a73ab227db354519b71d6c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a310d914d16438b6f3b5c2cbef3b4cb63a9d9d2f31a73ab227db354519b71d6c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a310d914d16438b6f3b5c2cbef3b4cb63a9d9d2f31a73ab227db354519b71d6c?s=96&d=mm&r=g","caption":"laurad"},"url":"https:\/\/www.lymphoma.ca\/fr\/author\/laurad\/"}]}},"_links":{"self":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/posts\/20874","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/comments?post=20874"}],"version-history":[{"count":5,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/posts\/20874\/revisions"}],"predecessor-version":[{"id":20879,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/posts\/20874\/revisions\/20879"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/media\/20870"}],"wp:attachment":[{"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/media?parent=20874"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/categories?post=20874"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.lymphoma.ca\/fr\/wp-json\/wp\/v2\/tags?post=20874"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}